当前蛋白身份:P52564 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
2Y8O Crystal structure of human p38alpha complexed with a MAPK docking peptide 提交 2011-02-08 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 4–17(14 aa) 片段:N-TERMINAL DOCKING PEPTIDE OF MKK6, RESIDUES 4-17
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 pH 7.5;22% PEG3350 100MM HEPES 7.5
分辨率 1.95 Å R-free 0.209
3ENM The structure of the MAP2K MEK6 reveals an autoinhibitory dimer 提交 2008-09-25 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 45–332(288 aa) 片段:residues 45-334
链 C 45–332(288 aa) 片段:residues 45-334
突变:S207D T211D 非标准单体:是(mmCIF未提供具体位点) 突变:S207D T211D 非标准单体:是(mmCIF未提供具体位点) SO4 SULFATE ION × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;1.6M Li2SO4 0.1M Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
分辨率 2.35 Å R-free 0.269
3ENM The structure of the MAP2K MEK6 reveals an autoinhibitory dimer 提交 2008-09-25 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 45–332(288 aa) 片段:residues 45-334
链 D 45–332(288 aa) 片段:residues 45-334
突变:S207D T211D 非标准单体:是(mmCIF未提供具体位点) 突变:S207D T211D 非标准单体:是(mmCIF未提供具体位点) SO4 SULFATE ION × 2 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;1.6M Li2SO4 0.1M Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
分辨率 2.35 Å R-free 0.269
3FME Crystal Structure of Human Mitogen-Activated Protein Kinase Kinase 6 (MEK6) Activated Mutant (S207D, T211D) 提交 2008-12-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 47–334(288 aa) 片段:UNP residues 47-334, Protein kinase domain
突变:S207D, T211D STU STAUROSPORINE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.9;277 K;0.05M Mg(COO)2 10w/v PEG_3350, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.26 Å R-free 0.236
3VN9 Rifined Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state 提交 2012-01-05 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–334(334 aa)
未记录 ANK 9-{5-O-[(R)-hydroxy{[(S)-hydroxy(phosphonoamino)phosphoryl]oxy}phosphoryl]-beta-L-ribofuranosyl}-9H-purin-6-amine × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;277 K;20% PEG4000, 10% 2-propanol, 0.1mol/L Na-HEPES-HCl, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.60 Å R-free 0.280
5ETF Structure of dead kinase MAPK14 with bound the KIM domain of MKK6 提交 2015-11-17 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 4–18(15 aa) 片段:UNP residues 4-18
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;25% (w/v) PEG 3350 and 0.1 mM Bis-Tris pH6.5
分辨率 2.40 Å R-free 0.231
8A8M Structure of the MAPK p38alpha in complex with its activating MAP2K MKK6 提交 2022-06-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 15–334(320 aa)
突变:S207D, T211D AP2 PHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER × 2 MG MAGNESIUM ION × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE;blot for 3.5 seconds
分辨率 4.00 Å
8P7J Crystal structure of MAP2K6 with a covalent compound GCL96 提交 2023-05-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 47–334(288 aa)
未记录 X3K N-[3-(1H-pyrrolo[2,3-b]pyridin-4-yl)phenyl]prop-2-enamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;0.05M magnesium chloride -- 30% PEG500MME -- 0.1M HEPES pH 7.5
分辨率 2.40 Å R-free 0.257
8P7J Crystal structure of MAP2K6 with a covalent compound GCL96 提交 2023-05-30 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 47–334(288 aa)
未记录 X3K N-[3-(1H-pyrrolo[2,3-b]pyridin-4-yl)phenyl]prop-2-enamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;0.05M magnesium chloride -- 30% PEG500MME -- 0.1M HEPES pH 7.5
分辨率 2.40 Å R-free 0.257
8PM3 Crystal structure of MAP2K6 with a covalent compound GCL94 提交 2023-06-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 47–334(288 aa)
未记录 ZLE ~{N}-[3-(2-azanylpyridin-4-yl)phenyl]propanamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293.15 K;0.05M magnesium chloride -- 30% PEG500MME -- 0.1M HEPES pH 7.5
分辨率 2.00 Å R-free 0.236
8PM3 Crystal structure of MAP2K6 with a covalent compound GCL94 提交 2023-06-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 47–334(288 aa)
未记录 ZLE ~{N}-[3-(2-azanylpyridin-4-yl)phenyl]propanamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293.15 K;0.05M magnesium chloride -- 30% PEG500MME -- 0.1M HEPES pH 7.5
分辨率 2.00 Å R-free 0.236
8PM3 Crystal structure of MAP2K6 with a covalent compound GCL94 提交 2023-06-28 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 47–334(288 aa)
未记录 ZLE ~{N}-[3-(2-azanylpyridin-4-yl)phenyl]propanamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293.15 K;0.05M magnesium chloride -- 30% PEG500MME -- 0.1M HEPES pH 7.5
分辨率 2.00 Å R-free 0.236
8PM3 Crystal structure of MAP2K6 with a covalent compound GCL94 提交 2023-06-28 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 47–334(288 aa)
未记录 ZLE ~{N}-[3-(2-azanylpyridin-4-yl)phenyl]propanamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293.15 K;0.05M magnesium chloride -- 30% PEG500MME -- 0.1M HEPES pH 7.5
分辨率 2.00 Å R-free 0.236
9M1Z Crystal Structure of MAP2K6 complexed with 5Z-7-oxozeaenol 提交 2025-02-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–334(334 aa)
未记录 1FM (3S,5Z,8S,9S,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M Citrate pH5.0, 20% PEG4000, 0.2 M L-proline
分辨率 3.00 Å R-free 0.332
9M1Z Crystal Structure of MAP2K6 complexed with 5Z-7-oxozeaenol 提交 2025-02-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–334(334 aa)
未记录 1FM (3S,5Z,8S,9S,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M Citrate pH5.0, 20% PEG4000, 0.2 M L-proline
分辨率 3.00 Å R-free 0.332
9M1Z Crystal Structure of MAP2K6 complexed with 5Z-7-oxozeaenol 提交 2025-02-26 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–334(334 aa)
未记录 1FM (3S,5Z,8S,9S,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M Citrate pH5.0, 20% PEG4000, 0.2 M L-proline
分辨率 3.00 Å R-free 0.332
9M1Z Crystal Structure of MAP2K6 complexed with 5Z-7-oxozeaenol 提交 2025-02-26 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–334(334 aa)
未记录 1FM (3S,5Z,8S,9S,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M Citrate pH5.0, 20% PEG4000, 0.2 M L-proline
分辨率 3.00 Å R-free 0.332